Entecavir

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3389 publications

Very late entecavir resistance after more than 10 years of therapy in a treatment-naïve patient with chronic hepatitis B genotype D3.

Very late entecavir resistance after more than 10 years of therapy in a treatment-naïve patient with chronic hepatitis B genotype D3.

Journal: Revista espanola de enfermedades digestivas
Published: June 18, 2026

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply.

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics
Published: May 15, 2026

Entecavir-Induced Lichenoid Drug Eruption: A Case Report.

Entecavir-Induced Lichenoid Drug Eruption: A Case Report.

Journal: Cureus
Published: May 11, 2026

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?

Journal: Alimentary pharmacology & therapeutics
Published: May 10, 2026

Hepatitis B: A Review.

Hepatitis B: A Review.

Journal: JAMA
Published: May 04, 2026

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study.

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study.

Journal: Journal of clinical medicine
Published: April 20, 2026

Outcomes of Nucleos(t)ide Analogue Discontinuation in Noncirrhotic Patients With Chronic Hepatitis B: A Retrospective Study.

Outcomes of Nucleos(t)ide Analogue Discontinuation in Noncirrhotic Patients With Chronic Hepatitis B: A Retrospective Study.

Journal: Cureus
Published: March 29, 2026

Seronegative Cryoglobulinemic Glomerulonephritis Coexisting With Primary Sjögren Syndrome and HBV Infection: A Diagnostic and Therapeutic Challenge.

Seronegative Cryoglobulinemic Glomerulonephritis Coexisting With Primary Sjögren Syndrome and HBV Infection: A Diagnostic and Therapeutic Challenge.

Journal: Kidney medicine
Published: March 19, 2026

Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis.

Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis.

Journal: Minerva gastroenterology
Published: March 18, 2026

Comparative effectiveness of antiviral therapies in chronic hepatitis B and C management.

Comparative effectiveness of antiviral therapies in chronic hepatitis B and C management.

Journal: Bioinformation
Published: March 01, 2026

Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma.

Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma.

Journal: World journal of biological chemistry
Published: February 25, 2026

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival.

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 17, 2026
Showing 1-12 of 3,389

Last Updated: 06/30/2026